Arcturus Therapeutics Holdings Inc (ARCT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Arcturus Therapeutics Holdings Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 14 | $160 | $23 | $80.36 | $31 | 159.23% |
The Trend in the Analyst Price Target
Over the past 36 weeks, ARCT's average price target has gone up $6.86.
Over the past 14 months, ARCT's average upside potential has been 81.64%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-24 | 14 | 160 | 23 | 80.36 | 31.22 | 157.4% |
| 2021-07-17 | 14 | 160 | 23 | 80.36 | 28.03 | 186.69% |
| 2021-07-10 | 14 | 160 | 23 | 80.36 | 32.09 | 150.42% |
| 2021-07-03 | 13 | 160 | 23 | 81.08 | 34.73 | 133.46% |
| 2021-06-26 | 13 | 160 | 23 | 81.08 | 34.74 | 133.39% |
| 2021-06-13 | 12 | 160 | 23 | 86.08 | 34.39 | 150.31% |
| 2021-06-05 | 13 | 160 | 23 | 81.85 | 30.74 | 166.27% |
| 2021-05-22 | 13 | 160 | 23 | 84.08 | 28.81 | 191.84% |
| 2021-05-15 | 13 | 160 | 23 | 84.08 | 28.86 | 191.34% |
| 2021-05-08 | 13 | 160 | 31 | 86.15 | 31.80 | 170.91% |
| 2021-04-25 | 13 | 160 | 31 | 86.15 | 36.17 | 138.18% |
| 2021-04-17 | 13 | 160 | 31 | 86.15 | 40.33 | 113.61% |
| 2021-04-10 | 13 | 160 | 31 | 86.15 | 37.00 | 132.84% |
| 2021-04-03 | 13 | 160 | 31 | 86.15 | 40.50 | 112.72% |
| 2021-03-20 | 13 | 160 | 31 | 86.15 | 46.40 | 85.67% |
| 2021-03-13 | 13 | 160 | 31 | 86.15 | 49.48 | 74.11% |
| 2021-03-06 | 13 | 160 | 31 | 87.31 | 43.19 | 102.15% |
| 2021-02-27 | 13 | 152 | 31 | 89.08 | 52.67 | 69.13% |
| 2021-02-20 | 13 | 152 | 31 | 89.08 | 66.98 | 32.99% |
| 2021-02-13 | 13 | 152 | 31 | 91.54 | 73.47 | 24.6% |
| 2021-02-06 | 13 | 152 | 31 | 91.54 | 85.05 | 7.63% |
| 2021-01-30 | 13 | 152 | 31 | 91.54 | 72.46 | 26.33% |
| 2021-01-23 | 13 | 152 | 31 | 91.54 | 67.70 | 35.21% |
| 2021-01-16 | 13 | 152 | 31 | 91.54 | 59.69 | 53.36% |
| 2021-01-09 | 13 | 152 | 31 | 96.23 | 69.66 | 38.14% |
| 2021-01-02 | 12 | 152 | 31 | 94.42 | 43.38 | 117.66% |
| 2020-12-26 | 13 | 172 | 31 | 106.15 | 98.13 | 8.17% |
| 2020-12-19 | 14 | 172 | 18 | 99.86 | 99.29 | 0.57% |
| 2020-12-10 | 14 | 172 | 18 | 94.79 | 105.45 | -10.11% |
| 2020-12-07 | 14 | 140 | 18 | 74.36 | 123.66 | -39.87% |
| 2020-11-28 | 14 | 84 | 18 | 66.50 | 76.00 | -12.5% |
| 2020-11-12 | 12 | 84 | 62 | 73.50 | 48.12 | 52.74% |
| 2020-10-25 | 12 | 82 | 65 | 74.83 | 49.37 | 51.57% |
| 2020-10-04 | 10 | 82 | 68 | 76.10 | 42.79 | 77.85% |
| 2020-09-16 | 10 | 82 | 68 | 76.10 | 44.80 | 69.87% |
| 2020-08-24 | 11 | 82 | 31 | 72.00 | 54.24 | 32.74% |
| 2020-08-11 | 10 | 82 | 31 | 71.50 | 49.25 | 45.18% |
| 2020-08-01 | 10 | 80 | 31 | 67.80 | 52.23 | 29.81% |
| 2020-07-23 | 9 | 80 | 31 | 66.78 | NA | NA% |
| 2020-07-15 | 9 | 72 | 31 | 60.67 | NA | NA% |
| 2020-07-11 | 8 | 69 | 31 | 55.12 | NA | NA% |
| 2020-06-20 | 8 | 69 | 31 | 55.12 | NA | NA% |
| 2020-06-08 | 9 | 69 | 18 | 51.00 | NA | NA% |
ARCT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.73 | 3 | 5 | 4 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
Over the past 52 weeks, ARCT's average broker recommendation rating worsened by 1.12.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Arcturus Therapeutics Holdings Inc's variance in analysts' estimates is lower than 0.689999999999998% of all US stocks.
- The number of analysts covering the stock of ARCT is higher than 99.81% of stocks in the small market cap category.
- ARCT has a greater average analyst price target than 95.78% of stocks in the small market cap category.
- Arcturus Therapeutics Holdings Inc's upside potential (average analyst target price relative to current price) is greater than 88.35% of all US stocks.
Stocks similar to Arcturus Therapeutics Holdings Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PTCT, NKTR and SGMO.
Is ARCT a Buy, Hold or Sell? See the POWR Ratings now!